Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282967669> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4282967669 endingPage "1527" @default.
- W4282967669 startingPage "1527" @default.
- W4282967669 abstract "Abstract Androgen receptor (AR) signaling is also regulated epigenetically by histone-modifying enzymes (histone deacetylases-HDACs) that result in the development and progression of prostate cancer (CaP). It has been established that the inhibition of HDACs suppresses CaP proliferation by inhibiting AR signaling via multiple mechanisms, including AR degradation. Hence, the goal of this study was to develop small molecules that employ multiple mechanisms to inhibit AR expression and promote its degradation, which would effectively control the emergence and treatment of castration-resistant prostate cancer (CRPC). Several rationally designed antiandrogen equipped HDAC inhibitors (HDACis) were synthesized, and their efficacy on CRPC growth was examined both in vitro and in vivo models. Results demonstrated that these compounds' target (HDAC and AR) binding properties translated into potent anticancer activity against AR+ CRPC cell lines and to a lesser extent in AR- CRPC cell lines. In addition, among these compounds, we found that SB-146, a nontoxic agent, not only inhibited the growth of AR+ CRPC cells at nanomolar IC50s without sparing toxicity to healthy prostate epithelial cells. Molecular analysis confirmed SB-146 downregulated the expressions of both AR and AR-spice variants (AR-SV) in CRPC cells. Further analyses revealed downregulation of AR downstream (PSA, HOXB13 and FOXA1) targets as well as AR-SV’s (NUP210 and SLC3A2) in CRPC cells. SB-146 was also able to overcome DHT-induced AR and AR-SV signaling in C4-2B and 22Rv1 cells. Assessment of SB-146’s therapeutic efficacy on in vivo models revealed that oral administration of this compound abrogated AR+ and AR-SV (C4-2B and 22Rv1) tumor growth in xenotransplanted nude mice models. Finally, immunohistochemical analysis confirmed SB-146’s target of both AR and AR-SVs on xenografted tumor tissues. Together these results confirm that SB-146 is a potent agent that inhibits AR signaling in CRPC cells. Citation Format: Uttara Saran, Balaji Chandrasekaran, Ashish Tyagi, Subhasish Tapadar, Bocheng Wu, Oyelere Adegboyega, Chendil Damodaran. Developing a multifaceted approach to target androgen receptor (AR) in castration resistant prostate cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1527." @default.
- W4282967669 created "2022-06-17" @default.
- W4282967669 creator A5008366094 @default.
- W4282967669 creator A5038413033 @default.
- W4282967669 creator A5038561739 @default.
- W4282967669 creator A5057490217 @default.
- W4282967669 creator A5062287236 @default.
- W4282967669 creator A5066507908 @default.
- W4282967669 creator A5077759533 @default.
- W4282967669 date "2022-06-15" @default.
- W4282967669 modified "2023-09-29" @default.
- W4282967669 title "Abstract 1527: Developing a multifaceted approach to target androgen receptor (AR) in castration resistant prostate cancer" @default.
- W4282967669 doi "https://doi.org/10.1158/1538-7445.am2022-1527" @default.
- W4282967669 hasPublicationYear "2022" @default.
- W4282967669 type Work @default.
- W4282967669 citedByCount "0" @default.
- W4282967669 crossrefType "journal-article" @default.
- W4282967669 hasAuthorship W4282967669A5008366094 @default.
- W4282967669 hasAuthorship W4282967669A5038413033 @default.
- W4282967669 hasAuthorship W4282967669A5038561739 @default.
- W4282967669 hasAuthorship W4282967669A5057490217 @default.
- W4282967669 hasAuthorship W4282967669A5062287236 @default.
- W4282967669 hasAuthorship W4282967669A5066507908 @default.
- W4282967669 hasAuthorship W4282967669A5077759533 @default.
- W4282967669 hasConcept C104317684 @default.
- W4282967669 hasConcept C121608353 @default.
- W4282967669 hasConcept C126322002 @default.
- W4282967669 hasConcept C127561419 @default.
- W4282967669 hasConcept C150903083 @default.
- W4282967669 hasConcept C185592680 @default.
- W4282967669 hasConcept C207001950 @default.
- W4282967669 hasConcept C2777911890 @default.
- W4282967669 hasConcept C2778305200 @default.
- W4282967669 hasConcept C2780192828 @default.
- W4282967669 hasConcept C502942594 @default.
- W4282967669 hasConcept C54355233 @default.
- W4282967669 hasConcept C55493867 @default.
- W4282967669 hasConcept C61367390 @default.
- W4282967669 hasConcept C62112901 @default.
- W4282967669 hasConcept C64927066 @default.
- W4282967669 hasConcept C71315377 @default.
- W4282967669 hasConcept C71924100 @default.
- W4282967669 hasConcept C81885089 @default.
- W4282967669 hasConcept C86803240 @default.
- W4282967669 hasConcept C98274493 @default.
- W4282967669 hasConceptScore W4282967669C104317684 @default.
- W4282967669 hasConceptScore W4282967669C121608353 @default.
- W4282967669 hasConceptScore W4282967669C126322002 @default.
- W4282967669 hasConceptScore W4282967669C127561419 @default.
- W4282967669 hasConceptScore W4282967669C150903083 @default.
- W4282967669 hasConceptScore W4282967669C185592680 @default.
- W4282967669 hasConceptScore W4282967669C207001950 @default.
- W4282967669 hasConceptScore W4282967669C2777911890 @default.
- W4282967669 hasConceptScore W4282967669C2778305200 @default.
- W4282967669 hasConceptScore W4282967669C2780192828 @default.
- W4282967669 hasConceptScore W4282967669C502942594 @default.
- W4282967669 hasConceptScore W4282967669C54355233 @default.
- W4282967669 hasConceptScore W4282967669C55493867 @default.
- W4282967669 hasConceptScore W4282967669C61367390 @default.
- W4282967669 hasConceptScore W4282967669C62112901 @default.
- W4282967669 hasConceptScore W4282967669C64927066 @default.
- W4282967669 hasConceptScore W4282967669C71315377 @default.
- W4282967669 hasConceptScore W4282967669C71924100 @default.
- W4282967669 hasConceptScore W4282967669C81885089 @default.
- W4282967669 hasConceptScore W4282967669C86803240 @default.
- W4282967669 hasConceptScore W4282967669C98274493 @default.
- W4282967669 hasIssue "12_Supplement" @default.
- W4282967669 hasLocation W42829676691 @default.
- W4282967669 hasOpenAccess W4282967669 @default.
- W4282967669 hasPrimaryLocation W42829676691 @default.
- W4282967669 hasRelatedWork W2015889618 @default.
- W4282967669 hasRelatedWork W2035125749 @default.
- W4282967669 hasRelatedWork W2082788526 @default.
- W4282967669 hasRelatedWork W2247837647 @default.
- W4282967669 hasRelatedWork W2772229485 @default.
- W4282967669 hasRelatedWork W3087152049 @default.
- W4282967669 hasRelatedWork W3155718207 @default.
- W4282967669 hasRelatedWork W4225134596 @default.
- W4282967669 hasRelatedWork W4241300757 @default.
- W4282967669 hasRelatedWork W4301179376 @default.
- W4282967669 hasVolume "82" @default.
- W4282967669 isParatext "false" @default.
- W4282967669 isRetracted "false" @default.
- W4282967669 workType "article" @default.